NITE trying to hold the line at 1.25. We'll see if someone is really desperate to cover their short, or accumulate.

We know that sometimes investigators are hired to try to find out information about progress of a clinical trial, to give a hedge fund or other entity information that others don't have. Wouldn't it be funny if this turned out to be a hedge fund with such info, trying to front-run news?